ACTBP13

Across TCGA pan-cancer cohorts, ACTBP13 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated ACTBP13 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ACTBP13 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ACTBP13 expression acts as an unfavorable survival marker, although some lineages such as BLCA and STAD show a favorable association.

BLCA, LIHC, and KIRC are the cancer types where ACTBP13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.522	0.243	.001	81	view →
LIHC	DFS	Tertile	All	0.275	0.493	<.001	48	view →
KIRC	DFS	Quartile	All	0.602	0.837	<.001	40	view →
THYM	DFS	Median	II,III,IV	0.573	0.903	.006	32	view →
STAD	DFS	Quartile	II,III,IV	0.774	0.448	.004	28	view →
LUAD	OS	Quartile	II,III,IV	0.700	0.893	.014	15	view →
MESO	DFS	Tertile	IV	0.217	0.495	.029	12	view →
COAD	DFS	Quartile	IV	0.718	0.279	<.001	12	view →
ACC	DFS	Tertile	IV	0.099	0.422	.027	12	view →
THCA	DFS	Median	II,III,IV	0.859	0.935	.011	11	view →
UVM	OS	Tertile	III,IV	0.223	0.709	.045	9	view →
ESCA	DFS	Quartile	All	0.122	1.000	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

ACTBP13–BLCA (OS)

Open the BLCA breakdown →